03:39 PM EST - Medicago Inc. : reported first-quarter loss of $3.71 million or $0.03 per share, compared to $2.62 million or $0.03 per share last year. For the quarter, the company had revenues of $34,000 generated by the completion of the proof of concept contract with the United States Army Research, Development and Engineering Command laboratory specifically the Edgewood Chemical Biological Centre Research & Technology Directorate. Medicago Inc.
shares T.MDG are trading down $0.01 at $0.49.
